Список литературы

50. Tomic V., Tomic J., Klaic D.Z., Kasum M., Kuna K. Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial. Eur. J. Obstet. Gynecol. Reprod. Biol. 2015; 186: 49–53. doi: 10.1016/j.ejogrb.2014.11.002.

51. Zargar M.N.S., Ejtahed M. Comparison the effectiveness of oral dydrogesterone, vaginal progesterone suppository and progesterone ampule for luteal phase support on pregnancy rate during ART cycles. Int. J. Pharma. Res. Allied Sci. 2016; 5: 229–236.

52. Riley R.D., Lambert P.C., Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. 2010; 340: c221. Epub 2010/02/09. https://doi.org/10.1136/bmj.c221PMID: 20139215.

53. Abdel-Razik M., El-Berry S., Mostafa A. The effects of nitric oxide donors on uterine artery and sub-endometrial blood flow in patients with unexplained recurrent abortion. J Reprod Infertil. 2014; 15: 142–146

54. Kaňová N., Bičiková M. Hyperandrogenic states in pregnancy. Physiol Res. 2011; 60(2): 243–252.

55. Wang M.H., Baskin L.S. Endocrine disruptors, genital development, and hypospadias. J Androl. 2008; 29(5): 499–505.

56. Nordic Pharma Limited. Gestone 50 mg/2 ml. Summary of Product Characteristics UK. 3 августа 2007 г.

57. Marcyrl Pharmaceutical Industries. Prontogest Progesterone 100 mg Ampoules. Patient Leaflet.

58. Paulson R.J., Collins M.G., Yankov V.I. Progesterone pharmacokinetics and pharmacodynamics with 3 dosages and 2 regimens of an effervescent micronized progesterone vaginal insert. J. Clin. Endocrinol. Metab. 2014; 99: 4241–4249. doi: 10.1210/jc.2013-3937.

59. Ganesh A., Chakravorty N., Mukherjee R. et al. Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in vitro fertilization: a randomized clinical study. Fertil Steril 2011; 95(6): 1961–1965.

60. Pang Y., Dong J., Thomas P. Progesterone increases nitric oxide synthesis in human vascular endothelial cells through activation of membrane progesterone receptor-α. Am. J. Physiol. Endocrinol. Metab. 2015; 308: E899–E911. doi: 10.1152/ajpendo.00527.2014.

61. Simoncini T., Caruso A., Giretti M.S., Scorticati C., Fu X.D., Garibaldi S., Baldacci C., Mannella P., Fornari L., Genazzani A.R. Effects of dydrogesterone and of its stable metabolite, 20-alpha-dihydrodydrogesterone, on nitric oxide synthesis in human endothelial cells. Fertil. Steril. 2006; 86: 1235–1242. doi: 10.1016/j. fertnstert.2006.05.018.

62. Fatemi H.M., Bourgain C., Donoso P. et al. Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept. Hum Reprod. 2007; 22(5): 1260–1263.

63. Saharkhiz N., Zamaniyan M., Salehpour S., Zadehmodarres S, Hoseini S., Cheraghi L. et al. A comparative study of dydrogesterone and micronized progesterone for luteal phase support during in vitro fertilization (IVF) cycles. Gynecol Endocrinol. 2016; 32(3): 213–7. https://doi.org/10.3109/09513590.2015. 1110136. PMID: 26486011.

64. Salehpour S., Tamimi M., Saharkhiz N. Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): a randomized clinical trial. Iran J. Reprod. Med. 2013; 11: 913–918.

65. Rashidi B.H., Ghazizadeh M., Tehrani Nejad E.S., Bagheri M., Gorginzadeh M. Oral dydrogesterone for luteal support in frozen-thawed embryo transfer artificial cycles: A pilot randomized controlled trial. Asian Pacific Journal of Reproduction. 2016; 5: 490–494. doi: 10.1016/j. apjr.2016.10.002.

66. Zarei A., Sohail P., Parsanezhad M.E., Alborzi S., Samsami A., Azizi M. Comparison of four protocols for luteal phase support in frozen-thawed Embryo transfer cycles: a randomized clinical trial. Arch. Gynecol. Obstet. 2017; 295: 239–246. doi: 10.1007/s00404-016-4217-4.

67. Сarp H.J.A. Progesterons in luteal support. Hormone Molecular Biology and Clinical Investigation. 2020. URL: http:/doi.org/10.1515/hmbci-2019-0067.

68. Schindler A.E. Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium. Maturitas 2009; 65(Suppl 1): S3–S11.

69. Schindler A.E., Campagnoli C., Druckmann R., Huber J., Pasqualini J.R., Schweppe K.W. et al. Classification and pharmacology of progestins. Maturitas. 2003; 46: S7–S16. Epub 2003/12/13. https://doi.org/10.1016/j.maturitas.2003.09.014. PMID: 14670641.

70. Chambers G.M., Hoang V.P., Zhu R., Illingworth P.J. A reduction in public funding for fertility treatment — an econometric analysis of access to treatment and savings to government. BMC Health Serv. Res. 2012; 12: 142. doi: 10.1186/1472-6963-12-142.

71. Colombo D., Ferraboschi P., Prestileo P., Toma L. A comparative molecular modeling study of dydrogesterone with other progestational agents through theoretical calculations and nuclear magnetic resonance spectroscopy. J. Steroid Biochem. Mol. Biol. 2006; 98: 56–62. doi: 10.1016/j.jsbmb.2005.07.009.

72. Paulson R.J., Collins M.G., Yankov V.I. Progesterone Pharmacokinetics and Pharmacodynamics With 3 Dosages and 2 Regimens of an Effervescent Micronized Progesterone Vaginal Insert. J Clin Endocrinol Metab. 2014; 99(11): 4241–4249.

Глава 21

1. Ramakrishnan U., Grant F., Goldenberg T., Zongrone A., Martorell R. (2012) Effect of women’s nutrition before and during early pregnancy on maternal and infant outcomes: a systematic review. Paediatr Perinat Epidemiol. 26: 285–301.

2. Cetin I., Berti C., Calabrese S. (2010) Role of micronutrients in the periconceptional period. Hum Reprod Update 16: 80–95.

3. Simpson J.L., Bailey L.B., Pietrzik K., Shane B., Holzgreve W. (2010) Micronutrients and women of reproductive potential: required dietary intake and consequences of dietary deficiency or excess. Part I-Folate, Vitamin B12, Vitamin B6. J Matern Fetal Neonatal Med 23: 1323–1343.

4. Simpson J.L., Bailey L.B., Pietrzik K., Shane B., Holzgreve W. (2011) Micronutrients and women of reproductive potential: required dietary intake and consequences of dietary deficiency or excess. Part II — vitamin D, vitamin A, iron, zinc, iodine, essential fatty acids. J Matern Fetal Neonatal Med 24: 1–24.

5. Singh S., Sedgh G., Hussain R. (2010) 8nintended pregnancy: worldwide levels, trends, and outcomes. Stud Fam Plann 41: 241–250.

6. Blumfeld M.L., Hure A.J., Macdonald-Wicks L., Smith R., Collins C.E. (2013) A systematic review and meta-analysis of micronutrient intakes during pregnancy in developed countries. Nutr Rev. 71: 118–132.

7. Elmadfa I., Meyer A., Nowa N.V., Hasenegger V., Putz P. et al. (2009) European Nutrition and Health Report. Forum Nutr. 62: 1–405.

8. World Health Organization and Food and Agricultural Organization of the 8nited Nations (1998, 2004). Iron. In: Vitamin and mineral requirements in human nutrition 2nd, Report of a joint FAO/W+2 expert consultation, Bangkok, Thailand, 21–30 September.

9. Young H., Borrel A., Holland D., Salama P. (2004) Public nutrition in complex emergencies. Lancet 364: 1899–1909.

10. Devakumar D., Fall C.H., Sachdev H.S., Margetts B.M., Osmond C., Wells J.C., Costello A., Osrin D. Maternal antenatal multiple micronutrient supplementation for long-term health benefits in children: a systematic review and meta-analysis. BMC Med. 2016 Jun 16; 14: 90. doi: 10.1186/s12916-016-0633-3.

11. Cobb C.M., Kelly P.J., Williams K.B., Babbar S., Angolkar M., Derman R.J. The oral microbiome and adverse pregnancy outcomes Int J Womens Health. 2017 Aug 8; 9: 551–559. doi: 10.2147/IJWH.S142730. eCollection 2017.

12. Lumley J., Watson L., Watson M., Bower C. (2001) Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database of Systematic Reviews 4: CD001056.

13. Persad 9L, Van den Hof MC, Dubé JM, Zimmer P (2002) Incidence of open neural tube defects in Nova Scotia after folic acid fortifcation. CMAJ 167: 241–245.

14. 3itNin RM (2007) Folate and neural tube defects. Am J Clin Nutr 85: 285S–288S.

15. Daly L.E., Kirke P.N., Molloy A., Weir D.G., Scott J.M. (1995) Folate levels and neural tube defects. Implications for prevention. JAMA 274: 1698–1702.

16. CusNelly G.J., McNulty H., Scott J.M. (1996) Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet 347: 657–659.

17. World Health Organization and Food and Agricultural Organization of the 8nited Nations (1998, 2004). Iron. In: Vitamin and mineral requirements in human nutrition 2nd, Report of a joint FAO/WHO expert consultation, Bangkok, Thailand, 21–30 September.

18. World Health Organization (2001) Iron defciency anaemia: assessment, prevention, and control. Geneva: WHO/NHD/01.3.

19. Simpson J.L., Bailey L.B., Pietrzik K., Shane B., Holzgreve W. (2011) Micronutrients and women of reproductive potential: required dietary intake and consequences of dietary defciency or excess. Part II — vitamin D, vitamin A, iron, zinc, iodine, essential fatty acids. J Matern Fetal Neonatal Med 24: 1–24.

20. Ramakrishnan U., Grant F., Goldenberg T., Zongrone A., Martorell R. (2012) Effect of women’s nutrition before and during early pregnancy on maternal and infant outcomes: a systematic review. Paediatr Perinat Epidemiol. 26: 285–301.

21. Shawe J., Delbaere I., Ekstrand M., Hegaard H.K., Larsson M. et al. (2015) Preconception care policy, guidelines, recommendations and services across six European countries: Belgium (Flanders), Denmark, Italy, the Netherlands, Sweden and the United Kingdom. Eur J Contracept Reprod Health Care. 20: 77–87.

22. Cetin I., Alvino G. (2009) Intrauterine growth restriction: implications for placental metabolism and transport. A review. Placenta. 30: S77–82.

23. Segal E., Dvorkin L., Lavy A., Rozen G.S., Yaniv I. et al. (2003) Bone density in axial and appendicular skeleton in patients with lactose intolerance: influence of calcium intake and vitamin D status. J Am Coll Nutr. 22: 201–207.

24. Russell J.A., Douglas A.J., Ingram C.D. Brain preparations for maternity — adaptive changes in behavioral and neuroendocrine systems during pregnancy and lactation. An overview. Prog Brain Res. 2001; 133: 1–38.